{"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"27"},{"groupId":"OG001","value":"7"},{"groupId":"OG002","value":"34"}]}],"title":"12 months"},{"categories":[{"measurements":[{"groupId":"OG000","value":"35"},{"groupId":"OG001","value":"10"},{"groupId":"OG002","value":"45"}]}],"title":"2 years"},{"categories":[{"measurements":[{"groupId":"OG000","value":"42"},{"groupId":"OG001","value":"14"},{"groupId":"OG002","value":"56"}]}],"title":"5 years"}],"denoms":[{"counts":[{"groupId":"OG000","value":"103"},{"groupId":"OG001","value":"48"},{"groupId":"OG002","value":"151"}],"units":"Participants"}],"description":"The incidence of cystectomy is described as the proportion of patients undergoing radical cystectomy for any reason after the first dose, within 12 months, 2 years and 5 years.","groups":[{"description":"Patients with Carcinoma in situ (CIS) with or without concomitant high-grade Ta or T1 papillary disease","id":"OG000","title":"Carcinoma in Situ"},{"description":"Patients with high-grade Ta or T1 papillary disease (without concomitant CIS)","id":"OG001","title":"Papillary Disease"},{"description":"All patients","id":"OG002","title":"Total"}],"paramType":"COUNT_OF_PARTICIPANTS","populationDescription":"Proportion of patients undergoing cystectomy within 5 years, 2 years and 12 months","reportingStatus":"POSTED","timeFrame":"60 Months","title":"Incidence of Cystectomy at 12 Months, 2 Years and 5 Years","type":"SECONDARY","unitOfMeasure":"Participants"}